CATALOGO DEI PRODOTTI DELLA RICERCA

CASTAGNA, Annalisa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.900
EU - Europa 3.194
AS - Asia 1.890
SA - Sud America 178
AF - Africa 23
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 2
Totale 9.196
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.881
GB - Regno Unito 982
CN - Cina 959
SG - Singapore 685
DE - Germania 360
SE - Svezia 339
IT - Italia 308
RU - Federazione Russa 286
FR - Francia 265
IE - Irlanda 257
FI - Finlandia 203
BR - Brasile 147
UA - Ucraina 69
JP - Giappone 61
BE - Belgio 45
VN - Vietnam 36
KR - Corea 30
HK - Hong Kong 29
TR - Turchia 19
NL - Olanda 15
CA - Canada 14
IN - India 14
ID - Indonesia 12
CL - Cile 10
AU - Australia 9
CH - Svizzera 8
IR - Iran 8
VE - Venezuela 7
AT - Austria 6
IL - Israele 6
TG - Togo 6
AR - Argentina 5
GR - Grecia 5
LT - Lituania 5
CZ - Repubblica Ceca 4
EE - Estonia 4
EG - Egitto 4
ES - Italia 4
PT - Portogallo 4
UZ - Uzbekistan 4
ZA - Sudafrica 4
DZ - Algeria 3
EC - Ecuador 3
HR - Croazia 3
HU - Ungheria 3
KG - Kirghizistan 3
LV - Lettonia 3
MA - Marocco 3
PK - Pakistan 3
AZ - Azerbaigian 2
BG - Bulgaria 2
BO - Bolivia 2
DK - Danimarca 2
IQ - Iraq 2
KE - Kenya 2
MX - Messico 2
NO - Norvegia 2
PE - Perù 2
PL - Polonia 2
TH - Thailandia 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
BD - Bangladesh 1
BH - Bahrain 1
CO - Colombia 1
DO - Repubblica Dominicana 1
EU - Europa 1
GE - Georgia 1
GT - Guatemala 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MD - Moldavia 1
MU - Mauritius 1
PH - Filippine 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 9.196
Salva come PNG Salva come JPEG
Città #
Southend 856
Chandler 741
Jacksonville 505
Singapore 431
Ann Arbor 359
Woodbridge 307
Dublin 257
Ashburn 207
Houston 203
Beijing 160
New York 133
Verona 121
Wilmington 119
Lawrence 102
Princeton 102
Jinan 83
Nanjing 77
Boardman 76
Shenyang 70
Helsinki 65
Tokyo 60
Brussels 45
Hebei 42
Redmond 35
Sindelfingen 34
Lancaster 33
The Dalles 33
Changsha 30
Tianjin 30
Zhengzhou 30
Haikou 29
Nanchang 29
Hong Kong 25
Jiaxing 24
Milan 24
Santa Clara 23
Munich 22
Dong Ket 20
Hangzhou 20
Taiyuan 20
Padova 19
Seattle 19
Guangzhou 18
Ningbo 17
Taizhou 17
Falls Church 15
Norwalk 15
Los Angeles 14
Nürnberg 14
Fuzhou 13
Seoul 13
Fairfield 12
Jakarta 12
São Paulo 12
Boydton 11
Council Bluffs 11
Dearborn 11
Redwood City 11
Toronto 11
Washington 10
Bologna 9
Dallas 9
Düsseldorf 9
Lanzhou 9
Zurich 8
London 7
San Mateo 7
Auburn Hills 6
Lomé 6
San Francisco 6
Shanghai 6
Trento 6
Ardabil 5
Clearwater 5
Kent 5
Meppel 5
Moscow 5
Bussolengo 4
Catanzaro 4
Las Vegas 4
Ospedaletto Euganeo 4
Riva 4
San Giovanni Lupatoto 4
Tashkent 4
Venice 4
Vienna 4
Amsterdam 3
Athens 3
Bangalore 3
Bishkek 3
Borgo Valsugana 3
Budapest 3
Cambridge 3
Canberra 3
Fermo 3
Frankfurt am Main 3
Groningen 3
Kharkov 3
Kochi 3
Madison 3
Totale 6.048
Salva come PNG Salva come JPEG
Nome #
Increased urinary excretion of the epithelial Na channel activator prostasin in patients with primary aldosteronism 248
Urinary prostasin in normotensive individuals: correlation with the aldosterone to renin ratio and urinary sodium. 142
Increased serum hepcidin levels in subjects with the metabolic syndrome: a population study. 134
The proteome: anno Domini 2002 124
Tarrgeted Exome Sequencing of 5 Hemochromatosis Genes in Iron Overloaded Patients by Next Generation Sequencing (NGS) Platform. 123
Identification of new BMP6 pro-peptide mutations in patients with iron overload 118
miRNAs purification and analysis from urinary exosomes. 117
Urinary protease inhibitor Serpin B3 is higher in women and is further increased in female patients affected by aldosterone producing adenoma 117
Immunoaffinity reactors for prion protein qualitative analysis 115
Apolipoprotein -CIII glycoforms correlate heterogeneously with plasma lipid profile in subjects with coronary artery disease 115
Serum levels of the hepcidin-20 isoform in a large general population: The Val Borbera study. 112
Hepcidin and DNA promoter methylation in hepatocellular carcinoma 111
Comparative two-dimensional mapping of prion protein isoforms in human cerebrospinal fluid and central nervous system 110
ApoCIII glycoforms determination and proteomic analysis in plasma of coronary patients with different ApoCIII levels . 109
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study 108
NT-proBNP, a useful tool in hypertensive patients undergoing a diagnostic evaluation for primary aldosteronism. 108
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population 107
HEPCIDIN REPRESSION BY PROMOTER DNA HYPERMETHYLATION IN NON-VIRAL HEPATOCELLULAR CARCINOMA 107
pH-dependent prion protein conformation in classical Creutzfeldt-Jakob disease 107
Isoelectric beads for proteome pre-fractionation.II :experimental evaluation in a multicompartment electroyzer 105
“Proteome analysis in the clinical chemistry laboratory: myth or reality?” 104
Alterations of systemic and muscle iron metabolism in human subjects treated with low-dose recombinant erythropoietin 102
Effects of female sex hormones and contraceptive pill on the diagnostic work-up for primary aldosteronism 102
Hepcidin Inhibition by Modified Heparins without Anticoagulant Activity 102
“Critical survey of quantitative proteomics in two-dimensional electrophoretic approaches” 101
Clinical, pathological, and molecular correlates in ferroportin disease: a study of two novel mutations. 101
“Proteomics approaches for studying chemoresistance in cancer” 100
"Exploring the hidden human urinary proteome via ligand library beads" 100
Altered iron parameters and hepcidin levels in a general population: lesson from the CHRIS study 100
Association of endogenous thrombin potential (ETP) with coronary artery disease. an angiography-based study. 99
Altered paraoxonase expression in patients with genetic haemochromatosis. 99
Evaluation of hepcidin isoforms in hemodialysis patients by a proteomic approach based on SELDI-TOF MS 98
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population. 95
Amphoteric,buffering chromatographic beads for proteome prefractionation.I :theoretical model 94
Urinary prostasin: a candidate marker of ENaC activation in humans:study of preliminary feasibility 94
Murine macrophages response to iron 94
Monocyte/macrophage proteomics: recent findings and biomedical applications. 93
How to bring the "unseen" proteome to the limelight via electrophoretic pre-fractionation techniques 93
Plasma proteomic analysis of patients with Coronary Artery Disease with different levels of apolipoprotein CIII 92
“Conventional isoelectric focusing in gel slabs and capillaries and immobilized pH gradients” 91
Prefractionation techniques in proteome analysis: the mining tools of the third millennium. 91
Epigenetic control of 11-beta-hydroxysteroid dehydrogenase 2 gene promoter is related to human hypertension 91
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study. 91
Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agents 91
Female urinary proteomics: New insight into exogenous and physiological hormone-dependent changes. 90
Apolipoprotein C-III glycoforms correlate heterogeneously with plasma lipid profile in subjects with coronary artery disease 90
Iron metabolism in Murine Macrophages: a proteomic insight. 89
A single dialysis session of hemodiafiltration with sorbent-regenerated endogenous ultrafiltrate reinfusion (HFR) removes hepcidin more efficiently than bicarbonate hemodialysis: a new approach to containing hepcidin burden in dialysis patients? 89
Epigenetics regulation of HSD11B2 gene by promoter methylation in glucocorticoid-treated patients 88
A proteomic approach to cisplatin resistance in the cervix squamous cell carcinoma cell line A431. 87
Apolipoprotein C-III Strongly Correlates with Activated Factor VII-Anti-Thrombin Complex: An Additional Link between Plasma Lipids and Coagulation 87
Surface plasmon resonance based on molecularly imprinted nanoparticles for the picomolar detection of the iron regulating hormone Hepcidin-25 86
Aceruloplasminemia: A Severe Neurodegenerative Disorder Deserving an Early Diagnosis 85
Epigenetic control of hydroxysteroid (11-beta) dehydrogenase 2 gene is related to human hypertension 83
Reduced serum hepcidin levels in patients with chronic hepatitis C 83
Carbamylation of proteins in 2-D electrophoresis--myth or reality? 82
Fully automated chemiluminescence vs RIA aldosterone assay in primary aldosteronism work-up 82
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis. 81
High resolution preparation of monocyte-derived macrophages (MDM) protein fractions for clinical proteomics 81
Increased plasma thrombin potential is associated with stable coronary artery disease: An angiographically-controlled study 81
Complement activation in the plasma and placentas of women with different subsets of antiphospholipid syndrome 81
Prefractionation techniques in proteome analysis. 80
Imprinted polymers for the recognition/quantitation of the peptide hormone hepcidin 80
Myristic acid plasma levels are strongly correlated with triglyceride and Apolipoprotein C-III plasma concentration in a cohort of subjects with or without coronary artery disease 80
Not Just Arterial Damage: Increased Incidence of Venous Thromboembolic Events in Cardiovascular Patients With Elevated Plasma Levels of Apolipoprotein CIII 80
Increased Incidence of Ischemic Cerebrovascular Events in Cardiovascular Patients With Elevated Apolipoprotein CIII 80
Optimizing the purification and analysis of miRNAs from urinary exosomes. 78
Anemia and Iron Deficiency in Cancer Patients: Role of Iron Replacement Therapy 77
Beta-elimination: an unexpected artefact in proteome analysis. 76
"Prefractionation of urinary proteins" 76
Effects of female sex hormones and contraceptive pill on the diagnostic work-up for primary aldosteronism 76
Prefractionation techniques in proteome analysis. 75
Myristic acid induces proteomic and secretomic changes associated with steatosis, cytoskeleton remodeling, endoplasmic reticulum stress, protein turnover and exosome release in HepG2 cells 75
The role of TMPRSS6 and HFE variants in iron deficiency anemia in celiac disease 74
Serum Uric Acid Levels, but Not rs7442295 Polymorphism of SCL2A9 Gene, Predict Mortality in Clinically Stable Coronary Artery Disease 74
Reducing protein concentration range of biological samples using solid-phase ligand libraries 72
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis 71
Provisional standardization of hepcidin assays: creating a traceability chain with a primary reference material, candidate reference method and a commutable secondary reference material 70
Detection of urinary exosomal HSD11B2 mRNA expression: a useful novel tool for the diagnostic approach of dysfunctional 11β-HSD2-related hypertension 70
Basophil Blood Cell Count Is Associated With Enhanced Factor II Plasma Coagulant Activity and Increased Risk of Mortality in Patients With Stable Coronary Artery Disease: Not Only Neutrophils as Prognostic Marker in Ischemic Heart Disease 69
”SPR biosensors and “natural hepcidin receptor” immobilization for hepcidin-25 determination in serum.” 67
Hormone-Dependent Changes in Female Urinary Proteome 67
Modern iron replacement therapy: clinical and pathophysiological insights 67
Trace Elements Status and Metallothioneins DNA Methylation Influence Human Hepatocellular Carcinoma Survival Rate 67
High Plasma Levels of Activated Factor VII-Antithrombin Complex Point to Increased Tissue Factor Expression in Patients with SARS-CoV-2 Pneumonia: A Potential Link with COVID-19 Prothrombotic Diathesis 66
Urinary Metabolic Signature of Primary Aldosteronism: Gender and Subtype-Specific Alterations 65
Plasma Proteome Profiles of Stable CAD Patients Stratified According to Total Apo C-III Levels 64
Hepcidin assay in serum by SELDI-TOF-MS and other approaches 63
Sucrosomial® Iron Supplementation in Mice: Effects on Blood Parameters, Hepcidin, and Inflammation 62
Hepcidin resistance in dysmetabolic iron overload 61
Aptamer-modified FXa generation assays to investigate hypercoagulability in plasma from patients with ischemic heart disease 61
A Novel ALAS2 Missense Mutation in Two Brothers With Iron Overload and Associated Alterations in Serum Hepcidin/Erythroferrone Levels 61
Measurament of urinary hepcidin levels by self-tof-ms in HFE-hemochromatosis 60
HFE mutations modulate the effect of iron on serum hepcidin-25 in chronic hemodialysis patients. 60
Recent trends in proteome analysis. 59
Sialylated isoforms of apolipoprotein C-III and plasma lipids in subjects with coronary artery disease 59
High Plasma Concentration of Apolipoprotein C-III Confers an Increased Risk of Cerebral Ischemic Events on Cardiovascular Patients Anticoagulated With Warfarin 53
The Positive Association between Plasma Myristic Acid and ApoCIII Concentrations in Cardiovascular Disease Patients Is Supported by the Effects of Myristic Acid in HepG2 Cells 52
Impact of natural Neuromedin-B receptor variants on iron metabolism 49
Treatment options for anemia in the elderly 48
Totale 8.844
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.194
article - articoli 27.778
book - libri 0
conference - conferenze 7.522
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 894
Totale 72.388
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020243 0 0 0 0 0 0 0 0 0 110 41 92
2020/2021839 61 122 64 107 109 89 25 53 45 25 91 48
2021/2022812 62 256 8 63 25 25 7 37 43 18 75 193
2022/20232.027 120 231 167 335 199 474 31 127 261 12 36 34
2023/20241.075 43 88 72 106 117 209 21 69 12 29 189 120
2024/20251.671 125 183 123 427 97 94 128 86 344 64 0 0
Totale 9.346